EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advances in the mechanisms of the NLRP3 inflammasome in sepsis‑induced cardiomyopathy and targeted therapeutic studies (Review)

Yifei Chen, Zhaohui Zhang, Gaosheng Zhou

Molecular Medicine Reports · 22.01.2026 · 33 (3) · 1-20

DOI: 10.3892/mmr.2026.13808 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 22.01.2026. Verfasst von Yifei Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei 443000, P.R. China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Sepsis, Inflammasomes, Cardiomyopathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a systemic inflammatory disorder characterized by multi‑organ dysfunction following infection. Sepsis‑induced cardiomyopathy (SIC) represents a prevalent complication that markedly contributes to in‑hospital mortality. The NOD‑like receptor protein 3 (NLRP3) inflammasome serves as an important regulator in SIC pathogenesis, directly impairing cardiac function through multiple mechanisms: i) Driving cytokine storms; ii) inducing cardiomyocyte pyroptosis and apoptosis; iii) disrupting mitochondrial homeostasis; and iv) suppressing autophagy. Molecularly‑targeted NLRP3 inhibitors have been developed, such as MCC950, curcumin, indole‑3‑propionic acid and carvacrol, which have demonstrated cardioprotective effects in cellular and animal models of SIC. Further exploration of NLRP3 mechanisms and resulting therapeutic targets may yield novel strategies for SIC diagnosis and clinical management. The present review examined NLRP3‑mediated pathways involving inflammation, programmed cell death and mitophagy in SIC pathogenesis, summarized pharmacological interventions targeting these pathways and highlighted previous advances in NLRP3 research to inform future therapeutic development and clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinSepsisInflammasomesCardiomyopathiesHumansAnimalsMolecular Targeted TherapySignal Transduction

Stichwörter der Autor:innen

NLRP3NLRP3 inhibitormechanismsepsis‑induced cardiomyopathy

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomes

Autor:innen und Institutionen

  • Department of Critical Care Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei 443000, P.R. China.

Zitieren

APA

Chen, Y., Zhang, Z., & Zhou, G. (2026). Advances in the mechanisms of the NLRP3 inflammasome in sepsis‑induced cardiomyopathy and targeted therapeutic studies (Review). Molecular Medicine Reports, 33(3), 1-20. https://doi.org/10.3892/mmr.2026.13808

Vancouver

Chen Y, Zhang Z, Zhou G. Advances in the mechanisms of the NLRP3 inflammasome in sepsis‑induced cardiomyopathy and targeted therapeutic studies (Review). Molecular Medicine Reports. 2026;33(3):1-20. doi:10.3892/mmr.2026.13808

BibTeX
@article{Chen2026,
  author = {Chen, Yifei and Zhang, Zhaohui and Zhou, Gaosheng},
  title = {Advances in the mechanisms of the NLRP3 inflammasome in sepsis‑induced cardiomyopathy and targeted therapeutic studies (Review)},
  journal = {Molecular Medicine Reports},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {1--20},
  doi = {10.3892/mmr.2026.13808}
}
Kostenlos starten →